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ABSTRACT 
Post-surgical chest tube removal (CTR) is associated with a significant pain and discomfort for patients. Current 
treatment strategies for reducing CTR-associated pain and anxiety are limited and partially efficacious. To de-
termine the effects of cold application, inhalation of lavender essential oil, and their combination on pain and 
anxiety during CTR was investigated. This randomized controlled open-label trial was conducted with 80 pa-
tients in the cardiac surgery intensive care unit who had a chest tube for duration of at least 24 hours after coro-
nary artery bypass grafting (CABG). Patients were randomized (n=20 in each group) to receive cold application, 
aromatherapy with lavender oil, cold application in combination with lavender oil inhalation, or none of the 
above interventions (control group). The intensity and quality of pain and anxiety were evaluated using the visu-
al analogue scale, short form and modified-McGill pain questionnaire (SFM-MPQ) and the Spielberger situa-
tional anxiety level inventory (STAII) scale, respectively. Patients in all treatment groups had significantly lower 
pain intensity and anxiety compared with the control group immediately, 5, 10 and 15 min after CTR. There was 
no statistically significant difference in the SFM-MPQ total scores between the intervention groups. With respect 
to anxiety score, there was a significantly reduced anxiety level immediately after CTR in the aromatherapy and 
cold-aromatherapy combination groups versus the cold application group. The present results suggested the effi-
cacy of cold application and aromatherapy with lavender oil in reducing pain and anxiety associated with post-
CABG CTR. 
 
Keywords: chest tube, pain, anxiety, cold application, Lavandula angustifolia, nursing 
 
Abbreviations: BMI: Body mass index; CABG: Coronary artery bypass grafting; CTR: Chest tube removal; 
GC: Gas chromatography; ICU: Intensive care unit; MS: Mass spectrometry; RI: Retention index; SFM-MPQ: 
Short form and modified-McGill pain questionnaire; STAII: Spielberger situational anxiety level inventory; 
VAS: Visual analogue scale 
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INTRODUCTION 
Insertion of chest tube following coro-
nary artery bypass grafting (CABG) is a fre-
quent practice aimed at maintaining hemo-
dynamic stability and cardiopulmonary func-
tion. Chest tube facilitates drainage of the 
air, blood and other fluids from the pleural, 
pericardial or mediastinal cavity and pre-
vents pleural effusion, pneumothorax and 
hemothorax. Chest tubes are typically re-
moved 24-48 hours after surgery, or when 
the excess air, blood, or fluid has been 
properly drained. The tube adheres to the 
surrounding tissues, and its removal and sep-
aration of adjoined tissues is painful for the 
patient (Demir and Khorshid, 2010). Docu-
mented sensations experienced during chest 
tube removal (CTR) include burning, pain, 
pulling, pressure, anxiety, fear and scrubbing 
(Houston and Jesurum, 1999; Ertug and Ulk-
er, 2012). The pain experienced during CTR 
has been reported by patients as moderate to 
severe (Otaibi et al., 2013).  
Pain-relieving drugs that are used for 
CTR-associated pain, especially opioids and 
NSAIDs, have partial efficacy and their use 
is associated with side effects such as respir-
atory distress, nausea, itching, and gastroin-
testinal bleeding. Hence, several attempts 
have been made to use non-pharmacological 
pain-relieving methods such as heat and cold 
therapy, hypnotism, music therapy and aro-
matherapy (Olapour et al., 2013). 
Cold applications are commonly used as 
a non-pharmacological method for pain re-
lief. Cold slows down tissue metabolism and 
nerve conduction velocity locally and also 
has vasoconstrictive, anti-inflammatory, an-
ti-spasmodic and analgesic effects. The anal-
gesic effects of cold treatment can also be 
explained by the Melzack and Wall’s gate 
control theory. According to this theory, the 
stimulus caused by CTR activates fibers 
within the parietal pleura, chest muscles, and 
chest tube insertion site. It is believed that 
activation of these pain transmitting fibers 
results in a release of various excitatory neu-
rotransmitters. Application of cold may lead 
to a reduction or reversal of the pain impulse 
via activating descending inhibitory neurons 
that block ascending nociceptive nerves orig-
inating from the substantia gelatinosa. Re-
duction of anxiety is another mechanism that 
can lead to a decreased perception of pain 
(Friesner et al., 2006; Demir and Khorshid, 
2010; Ertug and Ulker, 2012). 
Another non-pharmacological approach 
towards pain control is aromatherapy that is 
defined as the therapeutic use of essential 
oils derived from plants. Lavender oil, ob-
tained from the plant Lavandula angustifolia 
Mill. (lavender), is a commonly used agent 
in aromatherapy (Sasannejad et al., 2012; 
Bagheri-Nesami et al., 2014). Lavender oil 
has been reported to possess several thera-
peutic effects including anti-anxiety, seda-
tive, spasmolytic, antihypertensive, antimi-
crobial, antifungal, antiseptic and wound 
healing properties (Cavanagh and Wilkinson, 
2002; Morris, 2002; Gedney et al., 2004; Yip 
and Tse, 2006; Sasannejad et al., 2012; 
Bagheri-Nesami et al., 2014). The analgesic 
effects of lavender oil have been widely 
studied (Morris, 2002; Gedney et al., 2004; 
Yip and Tse, 2006; Sasannejad et al., 2012). 
It has been shown that lavender oil can re-
lieve the pain associated with different con-
ditions such as labor, needle insertion, dialy-
sis and headache (Sasannejad et al., 2012; 
Olapour et al., 2013; Bagheri-Nesami et al., 
2014). These effects of lavender oil are con-
sistent with the putative efficacy of aroma-
therapy in reducing anxiety and fatigue (Lee, 
2004; Babashahi et al., 2010). 
Owing to the contradictory results on the 
efficacy of conventional pharmacological 
methods in relieving CTR-associated pain 
and discomfort, the present research was 
conducted to examine the effects of cold ap-
plication, aromatherapy with lavender oil, 
and combination of both of these methods on 
the severity of pain and anxiety during CTR.  
 
MATERIALS AND METHODS 
Plant materials 
Lavender oil was provided by the Giah 
Essence Pharmaceutical Company (Gorgan-
Iran). The plant material was collected by 
Dr. H. Soleimani from the Tooskestan region 
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(altitude: 400 m) located at the Southeast 
Gorgan, Golestan province, Iran. The plant 
was identified by Mrs. Souzani and a vouch-
er sample (no. 13144) was identified and de-
posited in the herbarium of the School of 
Pharmacy, Mashhad University of Medical 
Sciences, Mashhad, Iran. Chemical composi-
tion of the essential oil was analyzed using 
Gas Chromatography (GC) and GC-Mass 
Spectrometry (GC-MS) methods. GC analy-
sis was performed using a Varian CP-3800 
apparatus equipped with a FID detector and 
fused silica column (CP-Sil 8CB, 50 m × 
0.25 mm, film thickness 0.12 m). The oper-
ating conditions were oven temperature 
50 °C (5 min), 50 °C-250 °C (3 °C /min), 
250 °C (10 min); injector temperature 
260 °C; split ratio 1:5; carrier gas N2 (2 ml/ 
min); and detector temperature 280 °C. 
GC-MS analyses were performed using 
an Agilent 5975 apparatus with a HP-5ms 
column (30 m × 0.25 mm, 0.25 µm film 
thickness) interfaced with a quadruple mass 
detector and a computer equipped with 
Wiley 7n.l library. The operating conditions 
were oven temperature 50 C (5 min), 50 C-
250 C (3 C/min), 250 C (10 min); injector 
temperature 250 °C; injection volume 
0.1 µL; split ration, 1:50; carrier gas Helium 
at 1.1 mL/min; ionization potential 70 eV; 
ionization current 150 µA; ion source tem-
perature 250 °C; and mass range 35-465 mui 
(Asili et al., 2009). 
The constituents of the oil were identi-
fied by calculation of their retention indices 
under temperature programmed conditions 
for n-alkanes (C8-C20) and the oil on a CP-
Sil 8CB column. Identification of individual 
compounds was made by comparison of their 
mass spectra and retention indices (RI) with 
those of authentic samples and those report-
ed in the literature (Adams, 2007; Bozi et al. 
2007; Facey et al. 2005). Quantification of 
the relative amount of the individual compo-
nents was performed according to the area 
percentage method without consideration of 
the calibration factor. 
 
Subjects 
Eighty ICU-hospitalized patients who 
had a chest tube for at least 24 hours after 
cardiothoracic surgery were included in this 
study. Other inclusion criteria were age 
> 18 yrs, body mass index (BMI) < 30 kg/ 
m2, full consciousness, ability to report pain, 
experiencing cardiac surgery and CTR for 
the first time, and having normal vital signs. 
Exclusion criteria were receiving mechanical 
ventilation support, continuous infusion of 
sedatives and analgesics or opioid analgesics 
during less than 4 hours before intervention, 
presence of psychiatric disease or any dis-
ease that could affect the research question 
(e.g. visual, auditory and smell defects), dif-
ficulty in breathing, nausea, vomiting, histo-
ry of hypersensitivity or dissatisfaction dur-
ing aromatherapy or cold application, and 
history of drug addiction or smoking.  
 
Design 
This study was a randomized compara-
tive trial with a factorial design that was 
conducted between December 2014 and 
March 2015 in the cardiac surgery intensive 
care unit (ICU) of the Imam Reza Hospital, 
Mashhad, Iran. Approval for the study was 
obtained from the Ethics Committee of the 
Mashhad University of Medical Sciences 
(Mashhad, Iran). Written informed consent 
was obtained from each participant prior to 
the study commencement. 
Eligible subjects were randomized (using 
random number tables) in an open-label 
fashion (using a random number table) to 
one of the following four groups: 
Group I: applied cold with cooling gel pack 
(cold group, n = 20). 
Group II: inhaled lavender essential oil 
(aroma group, n = 20). 
Group III: applied cold with cooling gel 
pack and inhaled lavender essential oil 
(cold-aroma group, n = 20). 
Group IV: did not receive either cold appli-
cation or lavender oil inhalation (control 
group, n = 20).  
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Data collection 
Pain intensity was measured using a ver-
tical visual analog scale (VAS) from 0 to 10 
(0= no pain, 10= worst pain imaginable). 
Numerous studies have used this scale to 
measure pain severity in CABG patients 
(Demir and Khorshid, 2010; Mazloum et al., 
2012; Gorgi et al., 2014). 
The short form and modified-McGill 
pain questionnaire (SFM-MPQ) was used to 
evaluate pain quality during CTR. Reliability 
and validity of the MPQ was previously es-
tablished by Melzack (1975). The validity of 
SFM-MPQ in Iranian subjects was estab-
lished by Mazloum et al. (2012). The relia-
bility coefficient of the tool for this study 
was reported to be 0.99 (Mazloum et al., 
2012). Validity and reliability was evaluated 
in our study. The Spielberger situational anx-
iety level inventory (STAII) was used to 
measure anxiety levels. The validity and reli-
ability of this scale has been established in 
the Iranian population by Nazemian et al. (r= 
0.89) (Nazemiyan et al., 2008). 
 
Procedures 
On the first postoperative morning, pa-
tients' readiness for CTR was determined by 
a physician according to the standard criteria. 
Patients were instructed by the researcher to 
use VAS, SFM-MPQ and STAII for rating 
pain intensity, quality and anxiety level. In 
addition, some information about cold appli-
cation and inhalation of lavender essential oil 
was presented to the participants. At 6 am 
CTR day, an ICU nurse administered 1 gr 
acetaminophen intravenously to all study 
subjects. Cold packs were kept in freezer for 
at least 2 h and then were covered with gauze 
or special pocket (according to the manufac-
turer’s leaflet) and applied to the area sur-
rounding the chest tube until the skin tem-
perature reached 13 °C. 
The researcher asked the patients to mark 
the pain intensity, quality and situational 
anxiety they felt with the chest tube in place. 
Pain intensity was measured 10 minutes be-
fore, and immediately, 5, 10, and 15 minutes 
after CTR. Pain quality and situational an-
xiety of the patients were measured 10 
minutes before and immediately after CTR. 
All patients were reassured that analgesic 
drugs would be administered as needed. All 
chest tubes were removed by the same ICU 
nurse to ensure the reliability of the results. 
The procedures for the application of cold 
and aromatherapy are as follows. 
 
Cold application 
In the cold application group, cooling gel 
packs (Dispotch Company, Italy) were used 
to reduce the body temperature around the 
chest tube during undressing. The bandage 
was removed from the chest area and body 
temperature was measured and recorded by a 
non-contact infrared thermometer (UNI-T 
912, Hong Kong). Then, a single layer of 
sterile gauze pad was placed around the skin 
area of pericardial tube insertion (according 
to the regulations of the Imam Reza cardiac 
surgery ICU, pericardial tube is the first tube 
that is removed) and cooling packs (14×18) 
were twisted in gauze and placed on top of it. 
Cold application was terminated when 
the skin temperature reached 13 °C. After 
removal of cooling packs, the nurse removed 
the pericardial tube within 1-2 minutes. The 
intensity and quality of pain experienced by 
the patient and the anxiety level were meas-
ured and recorded at the time points de-
scribed above.  
 
Aromatherapy 
In the aromatherapy group, 1-2 drops of 
aromatherapy blend containing lavender es-
sential oil were poured on cotton and fixed at 
a 10 cm distance from the patients' nose. The 
patient was asked to breathe slowly for 20 
minutes and then pain and anxiety were 
measured as described above. 
 
Statistical analysis 
SPSS software version 11.5 was used to 
analyze the recoded data. Descriptive statis-
tics were used to summarize demographic 
characteristics of the study participants. 
Normality of data were checked using Kol-
mogorov-Smirnov and Shapiro-Wilk tests. 
Baseline parameters of the study groups 
EXCLI Journal 2016;15:64-74 – ISSN 1611-2156 
Received: December 14, 2015, accepted: January 11, 2016, published: January 22, 2016 
 
 
68 
were compared using one-way ANOVA, 
Chi-square and Fisher’s exact tests were 
used. To compare the efficacy measures 
among the study groups, one-way ANOVA, 
Kruskal-Wallis, and repeated measures 
ANOVA tests were used. Bivariate correla-
tions between anxiety and pain scores before 
and immediately after CTR were performed 
using Pearson’s correlation coefficient. In all 
analyses, a two-sided P value of <0.05 was 
considered as statistically significant. 
 
RESULTS 
Essential oil composition 
Ninety-three compounds were identified 
in the lavender oil, representing 99.0 % of 
the total oil composition (Table 1). The main 
volatile constituents were linalool (21.1 %), 
1,8-cineol (15.7 %), and borneol (11. 6 %). 
The oil was predominated by oxygenated 
monoterpenes (81.3 %), followed by mono-
terpene hydrocarbons (7.2 %), oxygenated 
sesquiterpenes (4.8 %) and sesquiterpene 
hydrocarbons (3.6 %). 
 
 
Table 1: Essential oil components of the aerial 
parts of Lavandula angustifolia 
NO Compound RI 1  % 
1 tricyclene 926  t2 
2 cumene 929 0.0 
3 α-thujene 930 0.1 
4 α-pinene 937 0.8 
5 camphene 952 0.5 
6 verbenene 963 0.1 
7 benzaldehyde 965 t 
8 β-pinene 976 0.9 
9 1-octene-3-one 978 t
10 1-octene-3-ol 980 0.1 
11 3-Octanone 982 0.3 
12 myrcene 989 1.0 
13 3-Octanol  990 t 
14 butyl butanoate 993 t 
15 δ-2-carene 999 0.7 
16 hexyl acetate 1011 0.5 
17 ο-cymene 1015 0.4 
18 1,8-cineol 1029 15.7
19 cis-Ocimene 1035 0.7 
20 trans-Ocimene 1047 0.9 
21 γ-terpinene 1058 0.1 
22 cis-sabinene hydrate 1067 t 
23 trans-linalool oxide 1070 0.6 
24 terpinolene 1085 0.9 
NO Compound RI 1  % 
25 cis-linalool oxide 1087 0.4 
26 linalool 1102 21.1
27 1-octen-3-yl-acetate 1112 0.3 
28 nopinone 1137 0.2 
29 camphor 1143 9.0 
30 hexyl isobutanoate 1149 0.2 
31 isoborneol 1158 0.2 
32 pinocarvone 1160 t
33 borneol 1168 11.6
34 terpinen-4-ol 1175 0.7 
35 ρ-methyl-acetophenone 1180 0.1 
36 cryptone 1185 0.9 
37 α-terpineol 1189 6.2 
38 myrtenol 1194 0.2 
39 verbenone 1203 0.3 
40 trans-carveol 1215 0.3 
41 unknown 1219 0.6 
42 nerol 1228 0.9 
43 ρ-cumenol 1229 0.2 
44 cumin aldehyde 1237 1.1 
45 carvone 1241 0.5 
46 piperitone 1250 0.2 
47 linalyl acetate 1255 2.2 
48 geraniol  1257 2.1 
49 (E)-cinnamaldehyde 1265 0.2 
50 phellnderal 1268 0.5 
51 bornyl acetate 1283 0.3 
52 ρ-cymen-7-ol 1285 0.4 
53 lavandulyl acetate 1287 1.3 
54 thymol 1290 0.1 
55 carvacrol 1296 0.7 
56 hexyl tiglate 1328 0.4 
57 α-terpenyl acetate 1348 0.1 
58 neryl acetate 1364 1.0 
59 α-copaene 1373 t 
60 β-bourbonene 1382 0.1 
61 geranyl acetate 1383 2.0 
62 α-gurjunene 1403 0.2 
63 trans-caryophyllene 1415 1.0 
64 coumarin 1426 0.1 
65 α-trans-bergamotene 1434 0.1 
66 cis-β-farnesene 1441 0.1 
67 α-humulene 1451 0.1 
68 trans-β-farnesene 1456 0.4 
69 germacrene-D 1478 0.2 
70 AR-curcumene 1480 0.1 
71 β-E-ionene 1473 0.0 
72 α-muurolene 1497 0.1 
73 germacrene-A 1499 0.1 
74 β-bisabolene 1505 0.1 
75 γ-cadinene 1511 1.0 
76 cis-calamenene 1518 0.1 
77 δ-cadinene 1511 0.2 
78 trans-α-bisabolene 1532 t
79 unknown 1538 0.2 
80 spathulenol 1575 0.2 
81 caryophyllene oxide 1578 1.4 
82 viridiflorol 1588 t 
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NO Compound RI 1  % 
83 unknown 1589 0.2 
84 1,10-di-epi-cubenol 1613 0.2 
85 5-cedranone 1616 t 
86 epi-α-cadinol 1637 1.4 
87 α-muurolol 1644 t
88 α-cadinol 1650 0.2 
89 14-hydroxy-9-epi-
caryophyllene 
1663 0.1 
90 cadalene 1670 0.1 
91 α-bisabolol 1678 1.0 
92 Cadina-4,10(15)-dien-3-
one  
17394 0.1 
93 aristolene 1754 t 
 Major grouped  
compounds 
  
 Monoterpene  
hydrocarbons 
7.2  
 Oxygenated  
monoterpenes 
81.3  
 Sespuiterpene  
hydrocarbons 
3.6  
 Oxygented  
sesquiterpenes 
4.8  
 Miscellaneous  
compounds 
2.1  
 Total identified 99.0  
RI: The Kovats retention indices relative to C8-
C20 n-alkanes were determined on CP-Sil 8CB 
capillary column 
t: trace<0.05 % 
ρ-cumenol was identified by comparison of its RI 
with that given in the literature (Bozi et al., 2007). 
Cadina-4,10(15)-dien-3-one was identified by 
comparison of its RI with that given in the litera-
ture (Facey et al., 2005). 
 
 
Baseline and demographic characteristics 
The mean age of participants was 
54.3 ± 10.9 yrs. The study population con-
sisted of 56.2 % men and 43.8 % women, 
and distribution of genders among the study 
groups was similar (P=0.77). All subjects 
had two chest tubes (pericardial and left 
pleural) after CABG. 
Mean tube remaining time was 45.9±1.3 
hrs, and there was no significant difference 
among the study groups regarding this pa-
rameter (P=0.17). Likewise, the groups were 
comparable with respect to demographic 
characteristics including marital status 
(P=0.23), education (P=0.86), and residential 
status (urban or rural) (P=0.91), the worst 
pain experienced in the past (P=0.58) and its 
description (P=0.33). Baseline characteristics 
of the study groups are summarized in Table 
2.  
 
Pain intensity 
The study flow diagram is show in Fig-
ure 1. The pain intensity scores of the 4 
study groups in 5 time points (before, imme-
diately, 5, 10 and 15 min after CTR) are 
shown in Figure 2 and Table 3. There was no 
significant difference in the baseline pain 
intensity among the study groups (P=0.55). 
Repeated-measures analysis revealed a sig-
nificant increase in pain severity immediate-
ly after CTR, followed by a continuous de-
creasing trend until the last assessed time 
point in all study groups (P<0.001). Post-
hoc multiple comparisons revealed signifi-
cantly reduced pain intensity in all interven-
tion groups compared with the control group 
immediately after CTR, as well as at 5, 10 
and 15 min post-CTR time points. However, 
there was no significant difference among 
cold application, aromatherapy and cold-
aroma groups. 
 
 
 
Table 2: Comparison of baseline characteristics among the study groups 
Variable Cold Aroma Cold & Aroma Control P value 
Sleep (hour) 4.6 ± 2.3 5.8 ± 2.0 5.3 ± 1.7 4.7 ± 2.1 P=0.23 
Fatigue (score) 1.1 ± 1.5 1.0 ± 1.2 1.0 ± 0.9 1.0 ± 1.1 P=0.98 
The length of chest 
tube in the body (cm) 12.8 ± 2.3 13.0 ± 1.9 13.2 ± 1.9 13.0 ± 2.0 P=0.95 
Duration of chest 
tube in the body (cm) 46.4 ± 1.4 45.7 ± 1.2 45.6 ± 1.1 46.0 ± 1.3 P=0.17 
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Figure 1: Flow diagram of the study 
 
 
 
Figure 2: Trend of changes in pain intensity in the study groups at different time points 
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Table 3: Comparison of pain intensity scores among the study groups at different time points 
Repeated 
measures 
analysis 
15 min 
after CTR 
10 min  
after CTR 
5 min  
after CTR 
immediately 
after CTR 
Before  
intervention 
Pain  
Intensity 
 SD ± Mean SD ± Mean SD ± Mean SD ± Mean SD ± Mean Study groups 
F=39.54 
P<0.001 1.2 ± 1.7 1.9 ± 2.0 2.7 ± 2.1 4.4 ± 1.8 2.8 ± 2.0 Cold 
F=56.51 
P<0.001 1.6 ± 1.3 2.2 ± 1.5 2.9 ± 1.6 4.9 ± 1.9 3.1 ± 1.3 Aroma 
F=43.27 
P<0.001 0.9 ± 1.0 1.2 ± 1.1 2.0 ± 1.4 4.2 ± 1.9 3.3 ± 1.7 Cold & aroma 
F=48.16 
P<0.001 3.4 ± 1.6 3.8 ± 1.6 4.8 ± 1.4 6.5 ± 1.4 3.6 ± 1.5 Control 
F=8.47 
P<0.001 
F=11.92 
P<0.001 
F=9.89 
P<0.001 
F=10.41 
P<0.001 
F=7.12 
P<0.001 
F=0.71 
P=0.55 
Comparisons 
between 
groups 
ANOVA 
 
 
Pain quality 
The words selected by most of the sub-
jects to describe the present pain endured 
during CTR were “discomforting” (reported 
by 37.5 %), “distressing” (22.5 %), and “hor-
rible” (21.2 %). Also, the words selected by 
subjects to describe pain during CTR, ac-
cording to the SF-MPQ sclae were “fearful” 
(70 %), “shooting” (51.2 %), “tender” 
(51.2 %), “sickening” (48.8 %), “hot or 
burning” (46.2 %) and “sharp” (30 %). The 
total SFM-MPQ score in cold, aroma, cold-
aroma and control groups were 19.5±5.8, 
21.9±7.2, 17.1±9.9 and 29.1±5.5, respective-
ly. All interventions were associated with a 
reduced total SFM-MPQ score compared 
with the control group (P<0.001 [cold and 
cold-aroma groups] and P=0.020 [aroma 
group]); however, there was no statistically 
significant difference between the interven-
tions. 
 
Anxiety 
Table 4 represents the level of anxiety 
according to the STAII scale before and im-
mediately after CTR. Anxiety score de-
creased in all study groups (P<0.001). Post-
hoc multiple comparisons revealed a signifi-
cant difference between the aroma group 
with cold (P<0.009) and control groups 
(P<0.007), and also between the cold-aroma 
group with cold (P<0.001) and control 
groups (P<0.001). 
 
 
Table 4: Comparison of anxiety scores among different study groups 
Anxiety Score Before  
intervention 
Immediately 
after CTR 
Comparisons within 
group Paired t-test 
Anxiety Score 
Alteration 
Groups Mean ± SD Mean ± SD  Mean±SD 
Cold 36.2 ± 6.3 27.4 ± 3.9 t=9.95 P<0.001 -8.8 ± 3.9 
Aroma 38.2 ± 5.4 23.2 ± 3.8 t=14.42 P<0.001 -15.0 ± 4.7 
Cold & Aroma 37.2 ± 5.2 22.3 ± 4.5 t=21.72 P<0.001 -14.8 ± 3.1 
Control 33.9  ±4.8 27.5 ± 4.2 t=8.47 P<0.001 -6.4 ± 3.4 
Comparisons  
between groups 
ANOVA 
F=2.20 
P=0.09 
 
F=8.84 
P<0.001 
 
 
F=26.02 
P<0.001 
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Bivariate correlation analysis 
Bivariate correlations using Pearson’s 
correlation coefficients did not suggest any 
significant correlation between anxiety and 
pain scores either before or immediately af-
ter CTR. Likewise, there was no significant 
correlation between age, sleep duration, 
length of chest tube in the body, duration of 
chest tube presence in the body and fatigue 
score with either pain or anxiety score im-
mediately after CTR. 
 
DISCUSSION 
Findings of the present study showed that 
all three types of interventions (cold applica-
tion, inhalation of lavender essential oil, and 
combination of cold and lavender essential 
oil inhalation) could reduce pain and anxiety 
associated with CTR. However, there was no 
significant difference among the applied in-
terventions, and combination therapy did not 
further improve the analgesic and anti-
anxiety effects of each intervention. Al-
though numerous studies have shown the 
efficacy of non-pharmacological methods in 
reducing pain, to the best of authors’ 
knowledge, this is the first study comparing 
the effects of cold application and lavender 
aromatherapy in reducing the pain associated 
with CTR. In order to eliminate the con-
founding effect of surgery type and chest 
tube type on the study outcomes, CTR-
associated pain was assessed in subjects un-
dergoing pericardial tube removal following 
CABG.  
The composition of lavender oil that was 
used in this study was predominated by oxy-
genated monoterpenes. This result is consis-
tent with previous phytochemical reports on 
the same plant.  Barazandeh et al. (1999) 
studied the composition of the oil obtained 
from the aerial parts of L. angustifolia. The 
volatile oil of the herb had 19 compounds 
representing 90.4  % of the oil composition, 
and the main components were linalool 
(39.5 %), terpinen-4-ol (7.3 %) and linalyl 
acetate (32.4 %). Recently, Tayarani-Najaran 
et al. (2014) identified 80 compounds repre-
senting 97.4  % of the total lavender oil 
composition. The main compounds were re-
ported to be 1, 8-cineol (18.8 %) and borneol 
(19. 6 %). 
In previous studies, lavender oil was 
shown to be useful in reducing the pain asso-
ciated with migraine, cesarean section, and 
needle insertion into a fistula in hemodialysis 
patients (Sasannejad et al., 2012; Olapour et 
al., 2013; Bagheri-Nesami et al., 2014). 
There have been also some reports on the use 
of cold application for relieving the pain af-
ter CTR (Demir and Khorshid, 2010; 
Mazloum et al., 2012; Otaibi et al., 2013; 
Gorgi et al., 2014). Gorgi et al. (2014) stud-
ied the effects of relaxation and cold applica-
tion on the pain severity following cardiac 
surgery and reported a significant effect of 
both interventions versus control. Similar to 
the present study, the authors did not find 
any difference between the analgesic effects 
of cold application and relaxation; however, 
the impact of combination therapy with both 
methods was not investigated.  
Pain is a multidimensional sensation 
which is perceived in each subject different-
ly. It includes a blend of neurophysiologic, 
biochemical, cultural, cognitive, and envi-
ronmental dimensions (Sauls, 2002). In this 
study, we assessed all 11 quality descriptors 
of the SFM-MPQ scale to describe the quali-
ty of pain experienced after CTR, thus ena-
bling the participants to quantify and de-
scribe both sensory and affective compo-
nents of their pain experience. 
The MPQ words selected most frequently 
by subjects in this study were “fearful”, 
“shooting”, “tender”, “terrible” and “sting-
ing”. In earlier studies on CTR, the frequen-
cy of selection of “terrible” from the MPQ 
varied considerably. Sauls (2002) found 
these words were chosen less often than an-
other affective descriptor, “cramping” and 
“punishing-cruel”. In the study by Demir and 
Khorshid, “stinging” (86.7 %) and “sore” 
(74.4 %) were reported as the predominant 
descriptors of pain experienced during CTR 
(Demir and Khorshid, 2010). 
In the literature, there has been only a 
few studies related to anxiety associated with 
CTR. Mimnaugh et al. (1999) reported that 
anxiety levels were high in 77 % of patients 
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during CTR. Gift et al. (1991) also reported 
that the CTR procedure induces anxiety. In 
the Demir study, patients experienced high 
anxiety levels before CTR and moderate 
anxiety immediately after CTR, and there 
was no statistical difference in the variation 
of anxiety of patients among the groups re-
ceiving cold application, relaxation and con-
trol treatment (Demir and Khorshid, 2010). 
In the present study, anxiety scores were de-
creased in all groups immediately after CTR. 
The highest decrease was observed in the 
groups receiving aroma and cold-aroma 
combination. Overall, patients’ anxiety was 
improved by interventions compared with 
the control group; however, a moderate anxi-
ety level was still present immediately after 
CTR. 
As a limitation, this study was performed 
on a relatively small number of subjects and 
was limited to patients who underwent 
CABG surgery. Whilst this inclusion criteria 
increase the homogeneity of the study popu-
lation, it will make generalizability of find-
ings difficult. Moreover, the subjective na-
ture of efficacy measures might have intro-
duced bias into the results, though the effect 
of such a potential bias could be minimized 
by the randomized design of the study. Final-
ly, this study was performed in an open-label 
fashion because the nature of interventions 
made it impossible to design appropriate pla-
cebo. 
In conclusion, the findings of the present 
randomized controlled trial suggested that 
cold application, aromatherapy, and cold ap-
plication in combination with lavender oil 
inhalation could be used as non-
pharmacologic interventions to relieve pain 
associated with CTR. Given the simplicity 
and inexpensive nature of such approaches, 
their application in clinical practice could be 
suggested to the nursing staff. However, be-
fore routine application, confirmation of the 
present findings in larger scale trials, and in 
CTR-associated pain of non-CABG subjects 
is recommended.  
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